Improving Access Essential Tender

Access to medicines and technologies for non-communicable diseases is poor in low and middle-income countries. Building on the Swiss comparative advantage broader access engagement as a country with a big pharma sector the program addresses all components of the comprehensive framework for access to drugs ranging from research and innovation to dispensing and use. It will also set up a dedicated global collaborative network for advocacy information and innovation.CountryregionTopicPeriodBudgetGlobalHealthPrimary health careHealth systems strengthening01.11.2019 - 31.12.2031CHF 18000000 The project in briefDirectoratefederal office responsibleSDCCredit areaDevelopment cooperationProject partnersContract partnerSwiss Academic and Research InstitutionOther Swiss academic and research institutionsBudgetCurrent phaseSwiss budgetCHF 18000000Swiss disbursement to dateCHF 0Project phasesPhase 99 01.11.2019 - 31.12.2031 Current phase